Discovery research is a high-stakes bet. Will Lupin succeed where AstraZeneca, Novartis, and others failed?
Lupin has taken a big leap into the world of discovery research with the AbbVie deal. Its cancer-drug candidate faces a long journey ridden with hurdles. But in the world of cancer research, hope is the only motivation to find a cure.